D228

Revisión del cliente

Based on 1 Customer Validation

D228 is an orally active antiinflammatory agent. D228 reduces ConA induced T lymphocyte cell proliferation (IC50: 42.85 μM) and LPS induced B lymphocyte cell proliferation (IC50: 3.15 μM). D228 is effective against inflammatory bowel disease (IBD). D228 alleviates the DSS (HY-116282C)-induced inflammation response in the IBD model by downregulating the MyD88/TRAF6/p38 signaling.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.77%
  • No. CAS: 2676188-98-8
  • Fòrmula: C22H28O12
  • Peso molecular:484.45
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas p38 MAPK

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00